InvestorsHub Logo
Followers 1
Posts 500
Boards Moderated 0
Alias Born 01/31/2017

Re: None

Wednesday, 05/22/2019 4:15:57 PM

Wednesday, May 22, 2019 4:15:57 PM

Post# of 27120
Couple things here that seem to be intentionally left out:

The massive dip today: It could be a myriad things, but one that it is absolutely not, is insider buying/selling. They aren't allowed to trade in the blackout period, which is 30 days prior to earnings being released, and, since they're late on their 10-K, that means they haven't legally been able to buy or sell shares since early march. Don't believe me?, look it up on SEC's website. The conversion of low price shares from a partner could've been the case. As is a massive short position or some jackweed market maker tanking the price, there are market makers that specialize in shorting or bushwhacking distressed companies.

Restating Q3 & Q4 reports: If the reports have to be restated, then fine. The revenues will not be affected. Only the asset value of the IP/Patents/Equipment and convertible shares paid to the former owners of Medtainer. Which, may be a cause of the delay, because is the auditors finds that Acology overpaid for the product up front, they may be renegotiating the long term number of shares/cash being paid out. Which, if that's the case, would cause the former owners to raise hell, and wouldn't surprise me if that was *a* cause of the delay. And I honestly doubt any of you bozos looked at the assay of the IP/Patent lot and said to yourself you should buy a huge chunk of shares based solely on the asset value alone.

Jack Rein is not giving anyone *actual* material information. That is also illegal. The email floating around is legal speak platitudes that are intentionally vague. People who are saying "very soon" simply have no insight, nor actual knowledge of a release date. We are all in the same boat waiting for the same tide.